Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-10

FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approval overview for the generic anticonvulsant brivaracetam marketed by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)